BB4 antibody-Iodine 131

N/A

Report date: 2026/01/26 17:58:57

Base Information

Drug NameBB4 antibody-Iodine 131
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Iodine > 131IRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[5
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentre Rene Gauducheau
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre Rene Gauducheau
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A